LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1386

Search options

  1. Article ; Online: Overcoming the diagnostic challenges in a high-risk invasive primary cardiac lymphoma.

    Wang, Stephani C / Pan, Chris W

    European heart journal. Cardiovascular Imaging

    2020  Volume 21, Issue 6, Page(s) 707

    MeSH term(s) Heart Neoplasms/diagnostic imaging ; Heart Neoplasms/surgery ; Humans ; Lymphoma/diagnostic imaging
    Language English
    Publishing date 2020-01-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 2638345-7
    ISSN 2047-2412 ; 2047-2404
    ISSN (online) 2047-2412
    ISSN 2047-2404
    DOI 10.1093/ehjci/jez324
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cardiovascular protective properties of oxytocin against COVID-19.

    Wang, Stephani C / Wang, Yu-Feng

    Life sciences

    2021  Volume 270, Page(s) 119130

    Abstract: SARS-CoV-2 infection or COVID-19 has become a worldwide pandemic; however, effective treatment for COVID-19 remains to be established. Along with acute respiratory distress syndrome (ARDS), new and old cardiovascular injuries are important causes of ... ...

    Abstract SARS-CoV-2 infection or COVID-19 has become a worldwide pandemic; however, effective treatment for COVID-19 remains to be established. Along with acute respiratory distress syndrome (ARDS), new and old cardiovascular injuries are important causes of significant morbidity and mortality in COVID-19. Exploring new approaches managing cardiovascular complications is essential in controlling the disease progression and preventing long-term complications. Oxytocin (OXT), an immune-regulating neuropeptide, has recently emerged as a strong candidate for treatment and prevention of COVID-19 pandemic. OXT carries special functions in immunologic defense, homeostasis and surveillance. It suppresses neutrophil infiltration and inflammatory cytokine release, activates T-lymphocytes, and antagonizes negative effects of angiotensin II and other key pathological events of COVID-19. Additionally, OXT can promote γ-interferon expression to inhibit cathepsin L and increases superoxide dismutase expression to reduce heparin and heparan sulphate fragmentation. Through these mechanisms, OXT can block viral invasion, suppress cytokine storm, reverse lymphocytopenia, and prevent progression to ARDS and multiple organ failures. Importantly, besides prevention of metabolic disorders associated with atherosclerosis and diabetes mellitus, OXT can protect the heart and vasculature through suppressing hypertension and brain-heart syndrome, and promoting regeneration of injured cardiomyocytes. Unlike other therapeutic agents, exogenous OXT can be used safely without the side-effects seen in remdesivir and corticosteroid. Importantly, OXT can be mobilized endogenously to prevent pathogenesis of COVID-19. This article summarizes our current understandings of cardiovascular pathogenesis caused by COVID-19, explores the protective potentials of OXT against COVID-19-associated cardiovascular diseases, and discusses challenges in applying OXT in treatment and prevention of COVID-19. CHEMICAL COMPOUNDS: Angiotensin-converting enzyme 2 (ACE2); atrial natriuretic peptide (ANP); cathepsin L; heparan sulphate proteoglycans (HSPGs); interferon; interleukin; oxytocin; superoxide dismutase; transmembrane serine protease isoform 2 (TMPRSS2).
    MeSH term(s) Animals ; COVID-19/complications ; COVID-19/drug therapy ; COVID-19/prevention & control ; COVID-19/virology ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/virology ; Comorbidity ; Humans ; Oxytocin/adverse effects ; Oxytocin/therapeutic use ; SARS-CoV-2/physiology
    Chemical Substances Oxytocin (50-56-6)
    Language English
    Publishing date 2021-01-26
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.119130
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: On the elastic properties of arteries, by Stephanis, C.G., et al., 2000.; Journal of Biomechanics 36, 1727-1731.

    Wang, S-J Shyh-Jen / Wang, S-Y Shyh-Yau

    Journal of biomechanics

    2005  Volume 38, Issue 1, Page(s) 191; author reply 193

    MeSH term(s) Arteries/physiology ; Biomechanical Phenomena ; Elasticity ; Humans ; Models, Cardiovascular
    Language English
    Publishing date 2005-01
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 218076-5
    ISSN 1873-2380 ; 0021-9290
    ISSN (online) 1873-2380
    ISSN 0021-9290
    DOI 10.1016/j.jbiomech.2004.03.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Early recognition of mitral annular disjunction induced ventricular fibrillation: role of multimodality imaging.

    Wang, Stephani C / Lee, Mark / Cami, Elvis / Kern, Morton

    European heart journal. Cardiovascular Imaging

    2021  Volume 23, Issue 3, Page(s) e126

    MeSH term(s) Arrhythmias, Cardiac ; Humans ; Mitral Valve/diagnostic imaging ; Mitral Valve/surgery ; Mitral Valve Insufficiency/diagnostic imaging ; Mitral Valve Insufficiency/etiology ; Mitral Valve Insufficiency/surgery ; Mitral Valve Prolapse ; Ventricular Fibrillation/diagnostic imaging ; Ventricular Fibrillation/etiology ; Ventricular Fibrillation/therapy
    Language English
    Publishing date 2021-09-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 2638345-7
    ISSN 2047-2412 ; 2047-2404
    ISSN (online) 2047-2412
    ISSN 2047-2404
    DOI 10.1093/ehjci/jeab197
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Cardiovascular protective properties of oxytocin against COVID-19

    Wang, Stephani C / Wang, Yu-Feng

    Life sciences. 2021 Apr. 01, v. 270

    2021  

    Abstract: SARS-CoV-2 infection or COVID-19 has become a worldwide pandemic; however, effective treatment for COVID-19 remains to be established. Along with acute respiratory distress syndrome (ARDS), new and old cardiovascular injuries are important causes of ... ...

    Abstract SARS-CoV-2 infection or COVID-19 has become a worldwide pandemic; however, effective treatment for COVID-19 remains to be established. Along with acute respiratory distress syndrome (ARDS), new and old cardiovascular injuries are important causes of significant morbidity and mortality in COVID-19. Exploring new approaches managing cardiovascular complications is essential in controlling the disease progression and preventing long-term complications. Oxytocin (OXT), an immune-regulating neuropeptide, has recently emerged as a strong candidate for treatment and prevention of COVID-19 pandemic. OXT carries special functions in immunologic defense, homeostasis and surveillance. It suppresses neutrophil infiltration and inflammatory cytokine release, activates T-lymphocytes, and antagonizes negative effects of angiotensin II and other key pathological events of COVID-19. Additionally, OXT can promote γ-interferon expression to inhibit cathepsin L and increases superoxide dismutase expression to reduce heparin and heparan sulphate fragmentation. Through these mechanisms, OXT can block viral invasion, suppress cytokine storm, reverse lymphocytopenia, and prevent progression to ARDS and multiple organ failures. Importantly, besides prevention of metabolic disorders associated with atherosclerosis and diabetes mellitus, OXT can protect the heart and vasculature through suppressing hypertension and brain-heart syndrome, and promoting regeneration of injured cardiomyocytes. Unlike other therapeutic agents, exogenous OXT can be used safely without the side-effects seen in remdesivir and corticosteroid. Importantly, OXT can be mobilized endogenously to prevent pathogenesis of COVID-19. This article summarizes our current understandings of cardiovascular pathogenesis caused by COVID-19, explores the protective potentials of OXT against COVID-19-associated cardiovascular diseases, and discusses challenges in applying OXT in treatment and prevention of COVID-19.Angiotensin-converting enzyme 2 (ACE2); atrial natriuretic peptide (ANP); cathepsin L; heparan sulphate proteoglycans (HSPGs); interferon; interleukin; oxytocin; superoxide dismutase; transmembrane serine protease isoform 2 (TMPRSS2).
    Keywords COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; T-lymphocytes ; acute respiratory distress syndrome ; adrenal cortex hormones ; adverse effects ; atherosclerosis ; atrial natriuretic peptide ; cardiomyocytes ; cathepsin L ; diabetes mellitus ; disease progression ; heparan sulfate ; heparin ; homeostasis ; hypertension ; interleukins ; monitoring ; morbidity ; mortality ; neuropeptides ; neutrophils ; oxytocin ; pandemic ; pathogenesis ; proteoglycans ; serine proteinases ; superoxide dismutase ; therapeutics
    Language English
    Dates of publication 2021-0401
    Publishing place Elsevier Inc.
    Document type Article
    Note NAL-light
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2021.119130
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Astroglial Regulation of Magnocellular Neuroendocrine Cell Activities in the Supraoptic Nucleus.

    Wang, Stephani C / Parpura, Vladimir / Wang, Yu-Feng

    Neurochemical research

    2020  Volume 46, Issue 10, Page(s) 2586–2600

    Abstract: Studies on the interactions between astrocytes and neurons in the hypothalamo-neurohypophysial system have significantly facilitated our understanding of the regulation of neural activities. This has been exemplified in the interactions between ... ...

    Abstract Studies on the interactions between astrocytes and neurons in the hypothalamo-neurohypophysial system have significantly facilitated our understanding of the regulation of neural activities. This has been exemplified in the interactions between astrocytes and magnocellular neuroendocrine cells (MNCs) in the supraoptic nucleus (SON), specifically during osmotic stimulation and lactation. In response to changes in neurochemical environment in the SON, astrocytic morphology and functions change significantly, which further modulates MNC activity and the secretion of vasopressin and oxytocin. In osmotic regulation, short-term dehydration or water overload causes transient retraction or expansion of astrocytic processes, which increases or decreases the activity of SON neurons, respectively. Prolonged osmotic stimulation causes adaptive change in astrocytic plasticity in the SON, which allows osmosensory neurons to reserve osmosensitivity at new levels. During lactation, changes in neurochemical environment cause retraction of astrocytic processes around oxytocin neurons, which increases MNC's ability to secrete oxytocin. During suckling by a baby/pup, astrocytic processes in the mother/dams exhibit alternative retraction and expansion around oxytocin neurons, which mirrors intermittently synchronized activation of oxytocin neurons and the post-excitation inhibition, respectively. The morphological and functional plasticities of astrocytes depend on a series of cellular events involving glial fibrillary acidic protein, aquaporin 4, volume regulated anion channels, transporters and other astrocytic functional molecules. This review further explores mechanisms underlying astroglial regulation of the neuroendocrine neuronal activities in acute processes based on the knowledge from studies on the SON.
    MeSH term(s) Animals ; Aquaporin 4/metabolism ; Astrocytes/metabolism ; Glial Fibrillary Acidic Protein/metabolism ; Lactation/physiology ; Neuroendocrine Cells/metabolism ; Neuronal Plasticity/physiology ; Osmoregulation/physiology ; Supraoptic Nucleus/cytology ; Supraoptic Nucleus/metabolism
    Chemical Substances Aquaporin 4 ; Glial Fibrillary Acidic Protein
    Language English
    Publishing date 2020-11-20
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 199335-5
    ISSN 1573-6903 ; 0364-3190
    ISSN (online) 1573-6903
    ISSN 0364-3190
    DOI 10.1007/s11064-020-03172-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Native aortic valve thrombosis confined to noncoronary cusp of aortic valve.

    Wang, Stephani C / Guccione, Jack / Kim, Cy / Patel, Pranav M

    Acta cardiologica

    2020  Volume 76, Issue 6, Page(s) 672–673

    MeSH term(s) Aortic Diseases ; Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Insufficiency/diagnosis ; Aortic Valve Insufficiency/etiology ; Aortic Valve Insufficiency/surgery ; Heart Valve Diseases/diagnosis ; Humans ; Thrombosis/diagnosis ; Thrombosis/etiology
    Language English
    Publishing date 2020-05-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 390197-x
    ISSN 1784-973X ; 0001-5385
    ISSN (online) 1784-973X
    ISSN 0001-5385
    DOI 10.1080/00015385.2020.1764209
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Sex Differences Remain Under-Reported in Cardiovascular Publications.

    Wang, Stephani C / Koutroumpakis, Efstratios / Schulman-Marcus, Joshua / Tosh, Traci / Volgman, Annabelle Santos / Lyubarova, Radmila

    Journal of women's health (2002)

    2021  Volume 30, Issue 9, Page(s) 1253–1258

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) Female ; Humans ; Male ; National Institutes of Health (U.S.) ; Sex Characteristics ; United States
    Language English
    Publishing date 2021-03-05
    Publishing country United States
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 1139774-3
    ISSN 1931-843X ; 1059-7115 ; 1540-9996
    ISSN (online) 1931-843X
    ISSN 1059-7115 ; 1540-9996
    DOI 10.1089/jwh.2020.8561
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Regional Strain Pattern and Correlation with Cardiac Magnetic Resonance Imaging in Fabry Disease.

    Wang, Stephani C / Tapia, Daisy / Kimonis, Virginia E / Lombardo, Dawn M

    Journal of cardiovascular echography

    2021  Volume 31, Issue 3, Page(s) 131–136

    Abstract: Background: Cardiovascular disease is the most common cause of death among Fabry disease patients, who carry significantly increased risk for heart failure and sudden cardiac death. Echocardiographic strain imaging and cardiac MRI are important clinical ...

    Abstract Background: Cardiovascular disease is the most common cause of death among Fabry disease patients, who carry significantly increased risk for heart failure and sudden cardiac death. Echocardiographic strain imaging and cardiac MRI are important clinical tools for early detection of cardiomyopathy before onset of systolic or diastolic dysfunction. However, studies on these imaging modalities are limited among Fabry patients.
    Aim and objective: To evaluate echocardiographic strain pattern and correlation with cardiac MRI in Fabry disease.
    Materials and methods: We performed a detailed analysis of global longitudinal strain and correlation with cardiac MRI finding in 9 patients diagnosed with Fabry disease.
    Results: Despite normal left ventricular ejection fraction, basal and mid inferior segments are more likely to demonstrate strain abnormalities compared to other regions. Additionally, increased interventricular septal and left ventricular posterior wall thickness are correlated with greater strain abnormalities. Finally, MRI evidence of fibrosis and infiltration are detected among most patients with strain abnormalities, but in some cases, strain imaging were able to detect early evidence of cardiomyopathy even before MRI was fully able to detect the change. Basal and mid inferoseptal segment strain abnormalities are early signs of developing cardiomyopathy among patients with Fabry disease.
    Conclusion: Though cardiac MRIs are critical tools for detection of myocardial infiltration and scarring, these findings may not always be detectable in early phases of the disease. Multiple imaging modalities maybe considered in monitoring and evaluation of cardiomyopathy in Fabry disease.
    Language English
    Publishing date 2021-10-26
    Publishing country India
    Document type Journal Article
    ZDB-ID 2734045-4
    ISSN 2347-193X ; 2211-4122
    ISSN (online) 2347-193X
    ISSN 2211-4122
    DOI 10.4103/jcecho.jcecho_119_20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Characteristics of VCP mutation-associated cardiomyopathy.

    Wang, Stephani C / Smith, Charles D / Lombardo, Dawn M / Kimonis, Virginia

    Neuromuscular disorders : NMD

    2021  Volume 31, Issue 8, Page(s) 701–705

    Abstract: VCP associated inclusion body myopathy, Paget's disease of bone, and Frontotemporal Dementia (IBMPFD, VCP disease, or multisystem proteinopathy type 1 (MSP1)) is an autosomal dominant disease caused by missense mutations in the VCP gene, which plays a ... ...

    Abstract VCP associated inclusion body myopathy, Paget's disease of bone, and Frontotemporal Dementia (IBMPFD, VCP disease, or multisystem proteinopathy type 1 (MSP1)) is an autosomal dominant disease caused by missense mutations in the VCP gene, which plays a crucial role in ubiquitin-proteasome dependent degradation of cytosolic proteins. Those diagnosed with the disorder often suffer from cardiovascular complications in the advanced stages. We conducted an observational cross-section study to investigate echocardiographic features of asymptomatic carriers and those affected by the disease to determine the differences and potential early features of the VCP-associated cardiomyopathy. The study cohort constituted of 32 patients with VCP mutations including 23 affected individuals diagnosed with myopathy +/- Paget disease of bone, and 9 asymptomatic carriers. Among the affected individuals, 95.7% had myopathy, 43.5% had Paget's disease of bone, and none had frontotemporal dementia, and the carriers were asymptomatic. Not surprisingly the carriers were younger (mean age 38.4 ± 3.8 years), than the affected cohort (mean age 50.6 ± 9.1 years; p < 0.001). There was a 43.5% prevalence of diastolic dysfunction on echocardiogram among patients who were symptomatic from VCP disease, whereas none of the two asymptomatic carriers manifested diastolic dysfunction (p = 0.017). Among the 5 affected individuals who had consequential echocardiograms 2-3 years apart, three affected individuals developed diastolic dysfunction, and two already had diastolic dysfunction on the initial study. The two carriers did not develop diastolic function changes. This present study represents the largest series of echocardiograms performed in patients and asymptomatic carriers with VCP myopathy, and will pave the way for future, large-scale studies that may include other imaging modalities such as cardiac MRI and strain evaluation in patients at all stages of the disease.
    MeSH term(s) Adult ; Cohort Studies ; Cross-Sectional Studies ; Echocardiography ; Female ; Frontotemporal Dementia/diagnostic imaging ; Frontotemporal Dementia/genetics ; Genetic Predisposition to Disease ; Humans ; Male ; Middle Aged ; Muscular Dystrophies, Limb-Girdle/diagnostic imaging ; Muscular Dystrophies, Limb-Girdle/genetics ; Mutation ; Mutation, Missense ; Myositis, Inclusion Body/diagnostic imaging ; Myositis, Inclusion Body/genetics ; Osteitis Deformans/diagnostic imaging ; Osteitis Deformans/genetics ; Pedigree ; Ubiquitin/metabolism ; Valosin Containing Protein/genetics
    Chemical Substances Ubiquitin ; Valosin Containing Protein (EC 3.6.4.6)
    Language English
    Publishing date 2021-06-12
    Publishing country England
    Document type Journal Article ; Observational Study ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1077681-3
    ISSN 1873-2364 ; 0960-8966
    ISSN (online) 1873-2364
    ISSN 0960-8966
    DOI 10.1016/j.nmd.2021.06.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top